Skip to main content
Aptus Pharma Limited logo

Aptus Pharma Limited — Investor Relations & Filings

Ticker · 544529 ISIN · INE15XJ01010 LEI · 335800S67NKXF1BKVL66 BSE.NS Manufacturing
Open in API
Filings indexed 14 across all filing types
Latest filing 2026-06-09 Regulatory Filings
Country IN India
Listing BSE.NS 544529

About Aptus Pharma Limited

https://aptus-pharma.com/

Aptus Pharma Limited specializes in the development, manufacturing, and commercialization of a broad portfolio of pharmaceutical formulations. The company focuses on key therapeutic areas such as cardiovascular health, metabolic disorders, and gastrointestinal treatments. Its operational framework integrates advanced manufacturing technologies with stringent quality assurance protocols to ensure the production of high-standard medicinal products. The product range typically includes solid dosage forms like tablets and capsules, alongside liquid formulations. By prioritizing research and development, the organization seeks to provide effective and accessible therapeutic solutions tailored to diverse clinical requirements.

Recent filings

Filing Released Lang Actions
Trading window shall remain closed with effect from 09th June, 2026 (5:00 P. M.), i. e. from the date of Board Meeting intimation dated 09th June, 2026 until the expiry of 48 hours after ....
Regulatory Filings Classification · 85% confidence The document is a formal intimation to the stock exchange under SEBI Listing Regulations announcing the scheduling of a Board meeting and closure of the trading window. It does not contain financial statements, results, or definitive corporate actions—only a regulatory notice of a planned board meeting. This falls under general regulatory announcements, which are classified as Regulatory Filings (RNS).
2026-06-09 English
Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Regulatory Filings Classification · 85% confidence The document is a formal regulatory notice to a stock exchange notifying the scheduling of a Board meeting and related trading window closure under SEBI Listing Regulations. It does not contain financial results or report details, nor does it announce any director changes, dividends, or share issuances. It is a general compliance/regulatory announcement, so it falls under the fallback category RNS (Regulatory Filings).
2026-06-09 English
Announcement Under Regulation 30 (LODR): Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled as an 'Investor Presentation' and explicitly states it is prepared for dissemination to investors and analysts. It provides an overview of the company's business operations, financial performance, leadership, quality parameters, manufacturing facilities, and core values. The document is lengthy (15,000 characters) and contains detailed content typical of an investor presentation. It is not a brief announcement or a regulatory filing, nor is it a full annual or quarterly report with financial statements. The presence of slides and structured sections further confirms it is a presentation. Therefore, the document fits the category of an Investor Presentation (IP).
2026-05-29 English
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015: Brand Promotion Initiative at Rajkot Hirasar Airport
Regulatory Filings Classification · 85% confidence The document is an exchange filing to BSE under SEBI LODR Regulation 30 disclosing a brand promotion initiative. It is a routine regulatory disclosure announcing a material event rather than presenting financial results, management changes, or specific report content. It does not constitute an AGM presentation, earnings release, share issue, or any of the more specific categories. Therefore, it falls into the general “Regulatory Filings” category (RNS).
2026-05-22 English
Disclosure as per Regulation 7 (2) of SEBI (PIT) Regulations, 2015
Director's Dealing Classification · 91% confidence The document is a formal SEBI (PIT Regulations) disclosure on Form C of share transactions by promoters and insiders (buy/sale of equity shares) submitted to the stock exchange. This is an insider trading disclosure of personal share dealings by company directors/promoters. It therefore matches the “Director’s Dealing” category (insider trades), code DIRS.
2026-05-15 English
The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kripaliben Mayank Thakker
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011 (Regulation 29) providing detailed tables of share purchase percentages by a promoter group. This is not a company report nor a dividend or earnings release but a mandatory notification of a change in significant shareholding (crossing reporting thresholds). Therefore, it aligns with the “Major Shareholding Notification” category.
2026-05-14 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.